341 related articles for article (PubMed ID: 27174786)
1. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
[TBL] [Abstract][Full Text] [Related]
2. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma.
Zhang Y; Li JQ; Jiang ZZ; Li L; Wu Y; Zheng L
J Pathol; 2016 Jun; 239(2):231-41. PubMed ID: 27174787
[TBL] [Abstract][Full Text] [Related]
3. CD169
Batoon L; Millard SM; Wullschleger ME; Preda C; Wu AC; Kaur S; Tseng HW; Hume DA; Levesque JP; Raggatt LJ; Pettit AR
Biomaterials; 2019 Mar; 196():51-66. PubMed ID: 29107337
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow macrophages support prostate cancer growth in bone.
Soki FN; Cho SW; Kim YW; Jones JD; Park SI; Koh AJ; Entezami P; Daignault-Newton S; Pienta KJ; Roca H; McCauley LK
Oncotarget; 2015 Nov; 6(34):35782-96. PubMed ID: 26459393
[TBL] [Abstract][Full Text] [Related]
5. Reduced number of CD169
Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A
Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401
[TBL] [Abstract][Full Text] [Related]
6. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone.
Whang PG; Schwarz EM; Gamradt SC; Dougall WC; Lieberman JR
J Orthop Res; 2005 Nov; 23(6):1475-83. PubMed ID: 16005175
[TBL] [Abstract][Full Text] [Related]
7. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions.
Yonou H; Ochiai A; Goya M; Kanomata N; Hokama S; Morozumi M; Sugaya K; Hatano T; Ogawa Y
Prostate; 2004 Mar; 58(4):406-13. PubMed ID: 14968441
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer cells promote CD169
Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
[TBL] [Abstract][Full Text] [Related]
10. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
Wakchoure S; Swain TM; Hentunen TA; Bauskin AR; Brown DA; Breit SN; Vuopala KS; Harris KW; Selander KS
Prostate; 2009 May; 69(6):652-61. PubMed ID: 19152406
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
[TBL] [Abstract][Full Text] [Related]
12. CD169
Tacconi C; Commerford CD; Dieterich LC; Schwager S; He Y; Ikenberg K; Friebel E; Becher B; Tugues S; Detmar M
Cell Rep; 2021 Apr; 35(2):108993. PubMed ID: 33852863
[TBL] [Abstract][Full Text] [Related]
13. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
Lee YP; Schwarz EM; Davies M; Jo M; Gates J; Zhang X; Wu J; Lieberman JR
Cancer Res; 2002 Oct; 62(19):5564-70. PubMed ID: 12359769
[TBL] [Abstract][Full Text] [Related]
14. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
15. Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis.
Jones JD; Sinder BP; Paige D; Soki FN; Koh AJ; Thiele S; Shiozawa Y; Hofbauer LC; Daignault S; Roca H; McCauley LK
Neoplasia; 2019 Feb; 21(2):172-184. PubMed ID: 30591422
[TBL] [Abstract][Full Text] [Related]
16. Targeting macrophages for cancer therapy disrupts bone homeostasis and impairs bone marrow erythropoiesis in mice bearing Lewis lung carcinoma tumors.
Jing W; Zhang L; Qin F; Li X; Guo X; Li Y; Qiu C; Zhao Y
Cell Immunol; 2018 Sep; 331():168-177. PubMed ID: 30103869
[TBL] [Abstract][Full Text] [Related]
17. Melanoma growth and lymph node metastasis is independent of host CD169 expression.
Muhsin-Sharafaldine MR; Saunderson SC; Dunn AC; McLellan AD
Biochem Biophys Res Commun; 2017 May; 486(4):965-970. PubMed ID: 28359758
[TBL] [Abstract][Full Text] [Related]
18. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
[TBL] [Abstract][Full Text] [Related]
19. Loss of CD169
Topf MC; Harshyne L; Tuluc M; Mardekian S; Vimawala S; Cognetti DM; Curry JM; Rodeck U; Luginbuhl A
Otolaryngol Head Neck Surg; 2019 Jul; 161(1):67-73. PubMed ID: 30744470
[TBL] [Abstract][Full Text] [Related]
20. Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse.
Kim SW; Kim JS; Papadopoulos J; Choi HJ; He J; Maya M; Langley RR; Fan D; Fidler IJ; Kim SJ
Int Immunopharmacol; 2011 Jul; 11(7):862-72. PubMed ID: 21251905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
